🔎 Trials Near Me

홈 › 궤양성 대장염 › 루이지애나

루이지애나의 궤양성 대장염 임상 시험

궤양성 대장염 관련 연구 15개가 루이지애나 내 여러 지역에서 참여자를 모집하고 있습니다.

루이지애나의 도시

공식 연구 텍스트(영어)

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-008, Baton Rouge
  • Site US-011, Mandeville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07845487

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Gastro Group and Endocenter: Mandeville, la /ID# 284186, Mandeville
  • Metropolitan Gastroenterology Associates - Metairie /ID# 283922, Metairie
  • Willis-Knighton Medical Center /ID# 280572, Shreveport
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 035, Marrero
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07012395

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  • Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073), New Orleans
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07463183

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Delta Research Partners, LLC, West Monroe
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Care Access - New Iberia, New Iberia
  • Louisiana Research Center, Shreveport
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Gastro Group and Endocenter - Mandeville, Mandeville
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • GI Alliance, Metairie
  • Tulane University, New Orleans
피험자 모집 중4상
18세 ~ 65세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
  • Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128, Mandeville
  • Delta Research Partners - Site Number: 8400087, Monroe
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07185009

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Baton Rouge General Medical Center - Bluebonnet Campus, Baton Rouge
  • Combined Gastro LLC, Lafayette
  • GI Alliance, Metairie
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06581328

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Gastroenterology Clinic of Acadiana, Lafayette
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
  • Tandem Intermediate, LLC - Houma -Site Number: 8400034, Houma
  • GastroGroup - Site Number: 8400128, Mandeville
  • 외 4개
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07184996

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Clinical Trials Management, LLC, Metairie
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT06598943

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Lafayette
  • Mirador Therapeutics Selected Site, Marrero
  • Mirador Therapeutics Selected Site, Shreveport
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • Tulane University, New Orleans
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 5. 8. 업데이트됨 · NCT06750731

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.